Directors’ / PDMR Dealing and Grant of Options
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that it has granted options over a total of 2,176,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") to employees and Directors, of which 905,000 options were granted to Directors and PDMRs as detailed below. The options are part of annual awards made by Futura in accordance with existing share schemes.
| Director | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of Ordinary Shares held |
|---|---|---|---|---|---|
| J H Barder | 345,000 | 35.50p | 1 April 2027 - 31 Mar 2034 | 3,960,927 | 1,420,972 |
| A Hildreth | 280,000 | 35.50p | 1 April 2027 - 31 Mar 2034 | 3,320,082 | 142,857 |
| K W James | 280,000 | 35.50p | 1 April 2027 - 31 Mar 2034 | 3,655,953 | 299,581 |
Of the total 2,176,000 options, 1,611,000 were granted under the Futura Medical plc Enterprise Management Incentive Scheme, and 565,000 were granted under the unapproved scheme.
Vesting is subject to the achievement of a performance-related milestone and that the Director/PDMR/employee remains employed with the Company as at the date of exercise. Further disclosures are contained in the tables below.
| a) | Name | James Barder |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Futura Medical plc |
| b) | LEI | 21380053QLT46UNV2303 |
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares of 0.2 pence each GB0033278473 |
| b) | Nature of the transaction | Grant of options over Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) - 345,000 |
| d) | Aggregated information - Aggregated volume - Price | N/A single transaction |
| e) | Date of the transaction | 26 April 2024 |
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Angela Hildreth |
| 2 | Reason for the notification | |
| a) | Position/status | Finance Director and Chief Operating Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Futura Medical plc |
| b) | LEI | 21380053QLT46UNV2303 |
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares of 0.2 pence each GB0033278473 |
| b) | Nature of the transaction | Grant of options over Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) - 280,000 |
| d) | Aggregated information - Aggregated volume - Price | N/A single transaction |
| e) | Date of the transaction | 26 April 2024 |
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Ken James |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Director and Head of R&D |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Futura Medical plc |
| b) | LEI | 21380053QLT46UNV2303 |
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares of 0.2 pence each GB0033278473 |
| b) | Nature of the transaction | Grant of options over Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) - 280,000 |
| d) | Aggregated information - Aggregated volume - Price | N/A single transaction |
| e) | Date of the transaction | 26 April 2024 |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.